QIAGEN powered by

How a National Cancer Research Center Identifies Meaningful Mutations in Somatic Tumor Testing – Feb. 10

Date: 2022/02/10 Duration: 01:00:00 Presented by: Ana Krivokuca, PhD Head of Department for Genetic Counseling

In this webinar, Ana Krivokuca will present a real-world use case of how the Institute for Oncology and Radiology of Serbia (IORS), a national cancer research center that provides routine NGS testing for cancer patients, uses the Human Somatic Mutation Database (HSMD) in their NGS testing pipeline to validate, assess, and better understand the clinical significance of detected variants.

A new somatic database from QIAGEN, HSMD combines two decades of expert-curated content with data from over 300,000 real-world clinical oncology cases to provide deep genomic insight into the molecular characterizations of a patient’s tumor. Easy to search with new content added weekly, HSMD enables users to explore key genes or mutations with driving properties or clinical relevance, search for associated treatment options, evaluate secondary findings, and develop customized gene panels.

Attendees will:

  • Learn how IORS uses HSMD to identify actionable variants, analyze complex reports,  evaluate secondary findings, and design custom gene panels.
  • Explore HSMD content and features through a virtual demonstration.
  • Receive a complimentary, five-day trial of HSMD.

Click here to register.